정밀의료 소프트웨어 시장 - 세계 및 지역별 분석 : 제품 유형별, 용도별, 최종 사용자별, 지역별 - 분석 및 예측(2024-2033)
Precision Medicine Software Market - A Global and Regional Analysis: Focus on Product Type, Application, End User, and Region - Analysis and Forecast, 2024-2033
상품코드:1460108
리서치사:BIS Research
발행일:2024년 04월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계 정밀의료 소프트웨어 시장 규모는 2023년 18억 2,490만 달러에 달할 것으로 예상됩니다.
이 시장은 2024년부터 2033년까지 12.13%의 연평균 복합 성장률(CAGR)로 성장하여 2033년에는 56억 9,630만 달러에 달할 것으로 예측됩니다. 정밀의료 소프트웨어는 의료 분야에서 정밀의료 관행을 지원하고 강화하기 위해 설계된 전문 컴퓨터 프로그램 및 용도을 말합니다. 정밀의료는 맞춤형 의료라고도 불리며, 환자 개개인의 특성에 따라 의료 및 건강관리 결정을 내립니다. 이 접근법은 유전, 생활습관, 환경, 특정 분자 및 세포 특성 등의 요인을 고려합니다.
주요 시장 통계
예측 기간
2024년-2033년
2024년 평가
20억 3,000만 달러
2033년 전망
56억 9,000만 달러
CAGR
12.13%
정밀의료 소프트웨어는 획일적인 접근 방식에서 보다 개인화되고 효과적인 의료 모델로의 전환을 목표로 하는 헬스케어의 진화에 필수적인 요소입니다. 인공지능 및 머신러닝과 같은 첨단 기술의 통합은 정밀의료 소프트웨어가 복잡한 데이터 세트를 분석하고 개인화된 의료 전략을 위한 의미 있는 통찰력을 도출할 수 있는 능력을 더욱 향상시킬 것입니다.
정밀의료 소프트웨어 시장은 헬스케어와 첨단 기술의 융합에 힘입어 최근 몇 년동안 크게 성장하고 있습니다. 정밀의료는 유전적, 환경적, 생활습관상의 환자 개인차에 주목하는 것이 특징이며, 이는 전문 소프트웨어 솔루션의 개발 및 채택을 촉진하고 있습니다. 이러한 제품들은 게놈 분석, 임상 의사결정 지원, 데이터 통합, 환자 참여, 연구 지원 등 다양한 분야에 걸쳐 있습니다. 유전체 기술의 발전은 질병에 대한 유전적 관여에 대한 이해 증가와 함께 시장을 발전시키고 있습니다.
이 보고서는 세계 정밀의료 소프트웨어 시장을 조사했으며, 시장 개요와 함께 제품 유형별/용도별/최종사용자별/지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.
목차
주요 요약
제1장 시장
동향 : 현재 및 향후 영향 평가
공급망 개요
연구개발 리뷰
규제 상황
시장 역학 개요
제2장 용도
용도 세분화
용도 개요
세계의 정밀의료 소프트웨어 시장(용도별)
세계의 정밀의료 소프트웨어 시장(최종사용자별)
제3장 제품
제품 세분화
제품 개요
세계의 정밀의료 소프트웨어 시장(전개 모델별)
제4장 지역
지역별 개요
성장 촉진요인과 억제요인
북미
유럽
아시아태평양
기타 지역
제5장 시장 경쟁 벤치마킹과 기업 개요
향후 전망
지역적 평가
2bPrecise
F. Hoffmann-La Roche Ltd
Veracyte, Inc.
Roper Technologies, Inc.
Fabric Genomics, Inc.
Flatiron Health
Genedata AG
Koninklijke Philips N.V.
LifeOmic Holdings LLC
NantHealth, Inc.
PierianDx
QIAGEN N.V.
SOPHiA GENETICS SA
Syapse, Inc.
Tempus Labs, Inc.
제6장 조사 방법
LSH
영문 목차
영문목차
Global Precision Medicine Software Market Industry Overview
The global precision medicine software market was valued at $1,824.9 million in 2023 and is expected to reach $5,696.3 million by 2033, growing at a CAGR of 12.13% between 2024 and 2033. Precision medicine software refers to specialized computer programs or applications designed to support and enhance the practice of precision medicine in healthcare. Precision medicine, also known as personalized medicine, involves tailoring medical treatment and healthcare decisions to the individual characteristics of each patient. This approach considers factors such as genetics, lifestyle, environment, and specific molecular or cellular characteristics.
Market Introduction
KEY MARKET STATISTICS
Forecast Period
2024 - 2033
2024 Evaluation
$2.03 Billion
2033 Forecast
$5.69 Billion
CAGR
12.13%
Precision medicine software is a critical component of the evolving landscape of healthcare, aiming to move away from a one-size-fits-all approach to a more tailored and effective model of medical care. The integration of advanced technologies, such as artificial intelligence and machine learning, further enhances the capabilities of precision medicine software in analyzing complex datasets and deriving meaningful insights for personalized healthcare strategies.
The precision medicine software market has witnessed substantial growth in recent years, driven by the convergence of healthcare and cutting-edge technologies. Precision medicine, characterized by its focus on individual patient variability in genetics, environment, and lifestyle, has spurred the development and adoption of specialized software solutions. These offerings span genomics analysis, clinical decision support, data integration, patient engagement, and research support. Advancements in genomic technologies, coupled with a growing understanding of genetic contributions to diseases, have propelled the market forward.
Industrial Impact
The industrial impact on the precision medicine software market has been profound, with various sectors contributing to the growth and advancement of this specialized field. Industries such as biotechnology, pharmaceuticals, and information technology have played pivotal roles in driving innovation and shaping the landscape of precision medicine software. The biotechnology industry has been instrumental in the development of advanced genomic technologies, thereby making it feasible to analyze and interpret individual genetic data on a larger scale.
Market Segmentation:
Segmentation 1: by Delivery Mode
On-Premises Delivery Mode
Cloud-Based Delivery Mode
On-Premises Segment to Dominate the Precision Medicine Software Market (by Delivery Mode)
Based on delivery mode, the global precision medicine software market was led by the on-premises segment, which held a 65.38% share in 2023 primarily due to several key factors, such as heightened concerns regarding data security in the healthcare sector, which have driven organizations to opt for on-premises solutions, enabling them to maintain full control over sensitive patient information and ensure compliance with stringent regulatory standards such as HIPAA and GDPR. Moreover, the ability to customize software configurations and seamlessly integrate with existing legacy systems has made on-premises an attractive option for healthcare institutions with specific workflow requirements.
Segmentation 2: by Application
Oncology
Cardiovascular
Rare Diseases
Others
Oncology Segment to Dominate the Precision Medicine Software Market (by Application)
Based on application, the global precision medicine software market was led by the oncology segment, which held a 47.60% share in 2023, primarily due to the fact that oncology represents one of the most prominent areas of application for precision medicine, given the complex and diverse nature of cancer and the need for tailored treatment approaches. Precision medicine software offers advanced analytics and predictive modeling capabilities that are particularly well-suited to oncology, enabling healthcare providers to analyze genomic data, identify molecular biomarkers, and personalize treatment strategies based on individual patient characteristics.
Segmentation 3: by End User
Healthcare Providers
Research Centers and Government Institutes
Pharmaceutical and Biotechnology Companies
Other End Users
Healthcare Provider Segment to Dominate the Precision Medicine Software Market (by End User)
Based on end users, the global precision medicine software market was led by the healthcare providers segment, which held a 58.20% share in 2023, primarily because healthcare providers play a central role in the adoption and utilization of precision medicine software, as they are responsible for delivering personalized care to patients. Precision medicine software equips healthcare providers with advanced tools and analytics capabilities to analyze patient data, including genetic information, and tailor treatment plans accordingly. Additionally, healthcare providers are increasingly recognizing the potential of precision medicine to improve clinical outcomes, enhance patient satisfaction, and optimize resource utilization.
Segmentation 4: by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest-of-Europe
Asia-Pacific
Japan
India
China
South Korea
Australia
Rest-of-Asia-Pacific
Rest-of-the-World
Recent Developments in the Precision Medicine Software Market
In February 2024, Veracyte, Inc., a prominent cancer diagnostics company, concluded its acquisition of C2i Genomics. With this acquisition, Veracyte enhances its novel diagnostics platform by incorporating whole-genome minimal residual disease (MRD) capabilities. This expansion would broaden the company's capacity to support patients throughout the entire cancer care continuum.
In May 2023, F. Hoffmann-La Roche Ltd unveiled navify sample tracking, a cloud-based digital solution designed to assist laboratories in addressing quality challenges during the journey of diagnostic test samples.
In November 2023, Koninklijke Philips N.V. expanded its enterprise imaging portfolio and AI-enabled solutions. Philips HealthSuite Imaging, a next-generation cloud-based PACS, facilitates faster adoption of new capabilities for radiologists and clinicians. It aims to improve operational efficiency and enhance patient care. HealthSuite Imaging on Amazon Web Services (AWS) has introduced features such as high-speed remote access for diagnostic reading, integrated reporting, and AI-enabled workflow orchestration. All these capabilities are securely delivered through the cloud, aiming to ease the burden of IT management.
In November 2023, Fabric Genomics, a leading provider of AI-powered clinical next-generation sequencing (NGS) interpretation and reporting, collaborated with DNAnexus, Inc., a cloud-based data management pioneer. This collaboration would empower hospitals, clinical laboratories, and academic centers by enabling rapid access and analysis of large-scale clinical whole-genome data. The goal is to bring essential clinical insights to patients efficiently.
Demand - Drivers, Challenges, and Opportunities
Market Demand Drivers:
Utilizing Artificial Intelligence and Precision Medicine Together: The synergy between artificial intelligence (AI) and precision medicine is expected to be a powerful catalyst for the precision medicine software market. The integration of AI technologies would enhance the capabilities of precision medicine software by enabling advanced data analysis, rapid genomic interpretation, and personalized treatment recommendations.
Market Challenges:
Data Safety and Privacy Concerns: In the precision medicine software market, data safety and privacy concerns can pose significant restraints. Precision medicine involves collecting and analyzing sensitive personal information, such as genomic data, clinical records, and lifestyle details, thereby ensuring the security of this data, which is crucial. Patients and healthcare providers may be hesitant to embrace precision medicine solutions if they are uncertain about the robustness of data protection measures.
Market Opportunities:
Leveraging Electronic Health Records in the Market: Leveraging electronic health records (EHRs) in the precision medicine software market is a key strategy for enhancing personalized healthcare and improving patient outcomes. Precision medicine aims to tailor medical treatments and interventions to the individual characteristics of each patient, considering their genetic makeup, lifestyle, and environmental factors.
How Can This Report Add Value to an Organization?
Product/Innovation Strategy: The global precision medicine software market has been segmented based on various categories, such as product type, application, end user, and region.
Growth/Marketing Strategy: Product launches, upgradations, and synergistic activities together accounted for the maximum number of key developments, at nearly 88.24% of the total developments in the precision medicine software market between January 2021 and December 2023.
Competitive Strategy: The global precision medicine software market is a highly fragmented market, with many smaller and private companies constantly entering the market. Key players in the precision medicine software market analyzed and profiled in the study involve established players that offer various kinds of products.
Methodology
Key Considerations and Assumptions in Market Engineering and Validation
The base year considered for the calculation of the market size is 2022. A historical year analysis has been done for the period FY2019-FY2021. The market size has been estimated for FY2023 and projected for the period FY2024-FY2033.
The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of precision medicine software.
The market contribution of precision medicine software anticipated to be launched in the future has been calculated based on the historical analysis of the solutions.
Revenues of the companies have been referenced from their annual reports for FY2022 and FY2023. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, market collaborations, and operational history.
The market has been mapped based on the available precision medicine software. All the key companies with significant offerings in this field have been considered and profiled in this report.
Primary Research:
The primary sources involve industry experts in precision medicine, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.
The key data points taken from the primary sources include:
validation and triangulation of all the numbers and graphs
validation of the report's segmentation and key qualitative findings
understanding the competitive landscape and business model
current and proposed production values of a product by market players
validation of the numbers of the different segments of the market in focus
percentage split of individual markets for regional analysis
Secondary Research
The key data points taken from the secondary sources include:
segmentations and percentage shares
data for market value
key industry trends of the top players of the market
qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
quantitative data for mathematical and statistical calculations
Key Market Players and Competition Synopsis
The companies profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.
Some prominent names established in this market are:
2bPrecise
F. Hoffmann-La Roche Ltd
Veracyte, Inc.
Roper Technologies, Inc.
Fabric Genomics, Inc.
Flatiron Health
Genedata AG
Koninklijke Philips N.V.
LifeOmic Holdings LLC
NantHealth, Inc.
PierianDx
QIAGEN N.V.
SOPHiA GENETICS SA
Syapse, Inc.
Tempus Labs, Inc.
Table of Contents
Executive Summary
Scope and Definition
1 Markets
1.1 Trends: Current and Future Impact Assessment
1.1.1 Rise in Personalized Healthcare
1.1.2 Cloud-Based Delivery Mode-Based Platforms Elevating Data Accessibility
1.2 Supply Chain Overview
1.2.1 Value Chain Analysis
1.3 Research and Development Review
1.3.1 Patent Filing Trend
1.4 Regulatory Landscape
1.5 Market Dynamics Overview
1.5.1 Market Drivers
1.5.1.1 Utilizing Artificial Intelligence and Precision Medicine Together
1.5.1.2 Enhancement in the Precision Medicine Field Using Integrated and Automated Solutions
1.5.2 Market Restraints
1.5.2.1 Data Safety and Privacy Concerns
1.5.3 Market Opportunities
1.5.3.1 Leveraging Electronic Health Records in the Market
2 Application
2.1 Application Segmentation
2.2 Application Summary
2.3 Global Precision Medicine Software Market (by Application)
2.3.1 Oncology
2.3.2 Cardiovascular
2.3.3 Rare Diseases
2.3.4 Others
2.4 Global Precision Medicine Software Market (by End User)
2.4.1 Healthcare Providers
2.4.2 Research Centers and Government Institutes
2.4.3 Pharmaceutical and Biotechnology Companies
2.4.4 Other End Users
3 Products
3.1 Product Segmentation
3.2 Product Summary
3.3 Global Precision Medicine Software Market (by Delivery Model)
3.3.1 On-Premises Delivery Mode
3.3.2 Cloud-Based Delivery Mode
4 Regions
4.1 Regional Summary
4.2 Drivers and Restraints
4.3 North America
4.3.1 Regional Overview
4.3.2 Driving Factors for Market Growth
4.3.3 Factors Challenging the Market
4.3.4 Application
4.3.5 Product
4.3.6 U.S.
4.3.7 Application
4.3.8 Product
4.3.9 Canada
4.3.10 Application
4.3.11 Product
4.4 Europe
4.4.1 Regional Overview
4.4.2 Driving Factors for Market Growth
4.4.3 Factors Challenging the Market
4.4.4 Application
4.4.5 Product
4.4.6 France
4.4.7 Germany
4.4.8 U.K.
4.4.9 Spain
4.4.10 Italy
4.4.11 Rest-of-Europe
4.5 Asia-Pacific
4.5.1 Regional Overview
4.5.2 Driving Factors for Market Growth
4.5.3 Factors Challenging the Market
4.5.4 Application
4.5.5 Product
4.5.6 China
4.5.7 India
4.5.8 Australia
4.5.9 Japan
4.5.10 South Korea
4.5.11 Rest-of-Asia-Pacific
4.6 Rest-of-the-World
4.6.1 Regional Overview
4.6.2 Driving Factors for Market Growth
4.6.3 Factors Challenging the Market
4.6.4 Application
4.6.5 Product
5 Markets Competitive Benchmarking & Company Profiles
